Genome engineering using the CRISPR-Cas9 system View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2013-10-24

AUTHORS

F Ann Ran, Patrick D Hsu, Jason Wright, Vineeta Agarwala, David A Scott, Feng Zhang

ABSTRACT

Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1–2 weeks, and modified clonal cell lines can be derived within 2–3 weeks. More... »

PAGES

2281-2308

References to SciGraph publications

  • 2013-06-30. Heritable genome editing in C. elegans via a CRISPR-Cas9 system in NATURE METHODS
  • 2012-12-16. A ligation-independent cloning technique for high-throughput assembly of transcription activator–like effector genes in NATURE BIOTECHNOLOGY
  • 2011-07-17. High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases in NATURE METHODS
  • 2008-06-29. Establishment of HIV-1 resistance in CD4+ T cells by genome editing using zinc-finger nucleases in NATURE BIOTECHNOLOGY
  • 2012-01. Non-transgenic genome modifications in a hemimetabolous insect using zinc-finger and TAL effector nucleases in NATURE COMMUNICATIONS
  • 2008-05-29. A protocol for constructing gene targeting vectors: generating knockout mice for the cadherin family and beyond in NATURE PROTOCOLS
  • 2010-11-03. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA in NATURE
  • 2011-05-09. Evolution and classification of the CRISPR–Cas systems in NATURE REVIEWS MICROBIOLOGY
  • 2012-01-05. A transcription activator-like effector toolbox for genome engineering in NATURE PROTOCOLS
  • 2011-01-19. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription in NATURE BIOTECHNOLOGY
  • 2010-12-22. A TALE nuclease architecture for efficient genome editing in NATURE BIOTECHNOLOGY
  • 2007-07-01. An improved zinc-finger nuclease architecture for highly specific genome editing in NATURE BIOTECHNOLOGY
  • 1985-09. Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination in NATURE
  • 2010-06-25. A Rapid and General Assay for Monitoring Endogenous Gene Modification in ENGINEERED ZINC FINGER PROTEINS
  • 2002-05. Expanding small RNA interference in NATURE BIOTECHNOLOGY
  • 2010-09. Genome editing with engineered zinc finger nucleases in NATURE REVIEWS GENETICS
  • 2011-08-01. Genetic engineering of human pluripotent cells using TALE nucleases in NATURE BIOTECHNOLOGY
  • 2013-07-21. DNA targeting specificity of RNA-guided Cas9 nucleases in NATURE BIOTECHNOLOGY
  • 2012-04-22. Performance comparison of benchtop high-throughput sequencing platforms in NATURE BIOTECHNOLOGY
  • 2013-06-23. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells in NATURE BIOTECHNOLOGY
  • 2012-04-08. FLASH assembly of TALENs for high-throughput genome editing in NATURE BIOTECHNOLOGY
  • 2013-01-29. RNA-guided editing of bacterial genomes using CRISPR-Cas systems in NATURE BIOTECHNOLOGY
  • 2010-12-12. Selection-free zinc-finger-nuclease engineering by context-dependent assembly (CoDA) in NATURE METHODS
  • 2013-01-29. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease in NATURE BIOTECHNOLOGY
  • 2013-01-29. Efficient genome editing in zebrafish using a CRISPR-Cas system in NATURE BIOTECHNOLOGY
  • 2013-04-02. Generation of gene-modified mice via Cas9/RNA-mediated gene targeting in CELL RESEARCH
  • 2013-03-26. Genome editing with RNA-guided Cas9 nuclease in Zebrafish embryos in CELL RESEARCH
  • Journal

    TITLE

    Nature Protocols

    ISSUE

    11

    VOLUME

    8

    Related Patents

  • Agents Targeting Snat7 For Treating Cellular Metabolism Reprogramming-Associated Diseases
  • Methods And Compositions For Optochemical Control Of Crispr-Cas9
  • Production Of Viruses In Cell Culture
  • Methods And Compositions For The Targeted Modification Of A Mouse Genome
  • Processes And Systems For Preparation Of Nucleic Acid Sequencing Libraries And Libraries Prepared Using Same
  • Full Interrogation Of Nuclease Dsbs And Sequencing (Find-Seq)
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Adenosine Nucleobase Editors And Uses Thereof
  • Crispr-Based Genome Modification And Regulation
  • Full Interrogation Of Nuclease Dsbs And Sequencing (Find-Seq)
  • Method For Modifying Target Site In Double-Stranded Dna In Cell
  • Isolated Double Stranded Dna Polynucleotide
  • Protected Guide Rnas (Pgrnas)
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Compositions And Methods For Enhancing Homologous Recombination
  • Aav Delivery Of Nucleobase Editors
  • Systems, Methods, And Compositions For Targeted Nucleic Acid Editing
  • Method For Converting Genome Sequence Of Gram-Positive Bacterium By Specifically Converting Nucleic Acid Base Of Targeted Dna Sequence, And Molecular Complex Used In Same
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
  • Somatic Human Cell Line Mutations
  • Production Of Viruses In Avian Eggs
  • Retinoic Acid Receptor Gamma Agonists To Attenuate Anthracycline-Induced Cardiotoxicity
  • Compositions And Methods Of Improving Specificity In Genomic Engineering Using Rna-Guided Endonucleases
  • Anti-Cd103 Antibodies
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Uses Of Pyrimidopyrimidinones As Sik Inhibitors
  • Methods And Compositions For Modifying A Single Stranded Target Nucleic Acid
  • Materials And Methods For Treatment Of Spinocerebellar Ataxia Type 2 (Sca2) And Other Spinocerebellar Ataxia Type 2 Protein (Atxn2) Gene Related Conditions Or Disorders
  • B-1,4 Galactosylation Of Proteins
  • Cas9 Proteins Including Ligand-Dependent Inteins
  • Cas Variants For Gene Editing
  • Engineered Crispr-Cas9 Nucleases
  • Production Of Viruses In Cell Culture
  • Population Control Using Engineered Translocations
  • Optimized Crispr-Cas Double Nickase Systems, Methods And Compositions For Sequence Manipulation
  • Methods And Compositions For Modulating Microenvironment
  • Methods And Compositions For Detecting And Modulating Microenvironment Gene Signatures From The Csf Of Metastasis Patients
  • Delivery, Engineering And Optimization Of Tandem Guide Systems, Methods And Compositions For Sequence Manipulation
  • Nuclease Profiling System
  • Editing Of Ccr5 Receptor Gene To Protect Against Hiv Infection
  • Methods And Systems For Processing Polynucleotides
  • Novel Cas12b Enzymes And Systems
  • Method And Systems For Processing Polynucleotides
  • Genetically-Modified T Cells Comprising A Modified Intron In The T Cell Receptor Alpha Gene
  • Immune Effector Cell Therapies With Enhanced Efficacy
  • Methods And Compositions For Modulating Gene Expression
  • Massively Parallel Combinatorial Genetics For Crispr
  • Targeted In Situ Protein Diversification By Site Directed Dna Cleavage And Repair
  • Method For Gene Editing
  • Methods And Systems For Droplet-Based Single Cell Barcoding
  • Methods Of Treating Breast Cancer
  • Methods And Compositions For Treatment Of Disorders And Diseases Involving Rdh12
  • Rna-Guided Dna Integration Using Tn7-Like Transposons
  • Methods For Producing A Mouse Xy Embryonic (Es) Cell Line Capable Of Producing A Fertile Xy Female Mouse In An F0 Generation
  • Antibodies, Compounds And Screens For Identifying And Treating Cachexia Or Pre-Cachexia
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Genome Editing
  • Enrichment Of Genome-Edited Cells
  • Methods For Genomic Integration
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Methods For Preventing Or Treating Cancer Resistance To Egfr Inhibition
  • Methods And Genetic Systems For Cell Engineering
  • Methods And Compositions For Modifying A Targeted Locus
  • Genome Fractioning
  • Crispr Having Or Associated With Destabilization Domains
  • Targeted Modification Of Rat Genome
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Engineered Crispr-Cas9 Nucleases
  • Diffusible Factors And Cancer Cells
  • Plk4 Inhibitors
  • Modulation Of Novel Immune Checkpoint Targets
  • Partitioning And Processing Of Analytes And Other Species
  • Targeted Mutations
  • Antibodies, Compounds And Screens For Identifying And Treating Cachexia Or Pre-Cachexia
  • Functional Genomics Using Crispr-Cas Systems For Saturating Mutagenesis Of Non-Coding Elements, Compositions, Methods, Libraries And Applications Thereof
  • Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells
  • Systems And Methods For Quality Control In Single Cell Processing
  • Method For Targeted Knockout Of Human Lgals9 Gene Based On Crispr/Cas9 And Specific Grna Thereof
  • Method For Classifying A Patient's Responsiveness To Immune Checkpoint Inhibitor Therapy
  • Characterization And Inactivation Of Endogenous Retroviruses In Chinese Hamster Ovary Cells
  • Cas9 Proteins Including Ligand-Dependent Inteins
  • Methods For Identifying And Modulating Co-Occurant Cellular Phenotypes
  • Cas9-Based Isothermal Method Of Detection Of Specific Dna Sequence
  • Genome Editing Methods And Constructs
  • Method Of Engineering Chemotherapy Drug Resistant T-Cells For Immunotherapy
  • Massively Parallel Combinatorial Genetics For Crispr
  • Plk4 Inhibitors
  • Protected Guide Rnas (Pgrnas)
  • Methods And Systems For Processing Polynucleotides
  • Enhanced Disease Resistance Of Crops By Downregulation Of Repressor Genes
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Compositions Comprising Circular Polyribonucleotides And Uses Thereof
  • Rice Cells And Rice Plants
  • Isolated Double Stranded Dna Polynucleotide
  • Methods For The Identification And Isolation Of Hematopoietic Stem And Progenitor Cells
  • Methods And Systems For Processing Polynucleotides
  • Methods And Compositions For Modifying A Targeted Locus
  • Method For The Selection Of Cells Based On Crispr/Cas-Controlled Integration Of A Detectable Tag To A Target Protein
  • Method For Gene Editing
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Sequencing-Based Proteomics
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Targeting And Modeling Diseases And Disorders Of Post Mitotic Cells
  • Methods For Treating Metabolic Disorders By Targeting Adcy5
  • Engineered Transcription Activator-Like Effector (Tale) Domains And Uses Thereof
  • Coexpression Of Cas9 And Trex2 For Targeted Mutagenesis
  • Treatment And/Or Prevention Of Dna-Triplet Repeat Diseases Or Disorders
  • Methods For Modification Of Target Nucleic Acids Using A Fusion Molecule Of Guide And Donor Rna, Fusion Rna Molecule And Vector Systems Encoding The Fusion Rna Molecule
  • Adapters, Methods, And Compositions For Duplex Sequencing
  • Intracellular Genomic Transplant And Methods Of Therapy
  • Genome Editing Using Cas9 Nickases
  • Method And Systems For Processing Polynucleotides
  • Methods And Systems For Processing Polynucleotides
  • Methods For The Treatment Of Disease With Gene Editing Systems
  • Beta-1,4 Galactosylation Of Proteins
  • Methods For Identifying A Target Site Of A Cas9 Nuclease
  • Cas9-Based Isothermal Method Of Detection Of Specific Dna Sequence
  • Self-Limiting Viral Vectors Encoding Nucleases
  • Methods And Systems For Processing Polynucleotides
  • Methods And Systems For Processing Polynucleotides
  • Deletion Mutations
  • Adenosine Nucleobase Editors And Uses Thereof
  • Novel Delivery Of Large Payloads
  • Modulation Of Novel Immune Checkpoint Targets
  • Method For Gene Editing
  • Dual Aav Vector System For Crispr/Cas9 Mediated Correction Of Human Disease
  • Methods And Compositions For Targeted Genetic Modification Using Paired Guide Rnas
  • Cell Sorting
  • A Method Of Using Cut&Run Or Cut&Tag To Validate Crispr-Cas Targeting
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Engineered Crispr-Cas9 Nucleases
  • Methods And Systems For Processing Polynucleotides
  • Method Of Engineering Chemotherapy Drug Resistant T-Cells For Immunotherapy
  • Microfluidic Systems And Methods Of Use
  • Genomic Sequence Modification Method For Specifically Converting Nucleic Acid Bases Of Targeted Dna Sequence, And Molecular Complex For Use In Same
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Methods For Improving Production Of Biological Products By Reducing The Level Of Endogenous Protein
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Particle Delivery Components
  • Oncolytic Viral Vectors And Uses Thereof
  • Crispr-Based Genome Modification And Regulation
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Particle Delivery Components
  • Engineered Crispr-Cas9 Nucleases
  • Methods And Systems For Processing Polynucleotides
  • Mammalian Cell Line For Protein Production And Library Generation
  • Nucleobase Editors Comprising Nucleic Acid Programmable Dna Binding Proteins
  • Targeted Genome Editing In Zygotes Of Domestic Large Animals
  • Methods And Systems For Processing Polynucleotides
  • Plant Haploid Induction
  • Novel Crispr Enzymes And Systems
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Single Cell Analysis Of Transposase Accessible Chromatin
  • Gene Editing-Based Method Of Attenuating The Beta-Amyloid Pathway
  • Method Of Inhibiting Plant Virus Pathogen Infections By Crispr/Cas9-Mediated Interference
  • Compositions And Methods For High Efficiency In Vivo Genome Editing
  • Tumor Infiltrating Lymphocytes And Methods Of Therapy
  • Chemically Modified Guide Rnas For Crispr/Cas-Mediated Gene Regulation
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Targeting Disorders And Diseases Using Viral Components
  • Multiplex Guide Rnas
  • Compositions Comprising Circular Polyribonucleotides And Uses Thereof
  • Methods And Systems For Processing Polynucleotides
  • Methods And Systems For Processing Polynucleotides
  • System For Genome Editing
  • Methods And Compositions For The Targeted Modification Of A Mouse Embryonic Stem Cell Genome
  • Analysis Of Crispr-Cas Binding And Cleavage Sites Followed By High-Throughput Sequencing (Abc-Seq)
  • Methods For Identifying And Modulating Co-Occurant Cellular Phenotypes
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic Applications
  • Genomic Sequence Modification Method For Specifically Converting Nucleic Acid Bases Of Targeted Dna Sequence, And Molecular Complex For Use In Same
  • Homologous Recombination Factors
  • Methods And Systems For Processing Polynucleotides
  • Compositions For Use In Treating Autosomal Dominant Best1-Related Retinopathies
  • Methods And Compositions For Targeted Genetic Modification Through Single-Step Multiple Targeting
  • Compositions And Methods For High Efficiency In Vivo Genome Editing
  • Nanoparticle-Protein Complex For Intracellular Protein Delivery
  • Genome Editing For The Treatment Of Huntington's Disease
  • Disrupting The Linc Complex For Treating Laminopathy
  • Methods For Cleaving A Target Dna Using A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein
  • Shmt Inhibitors
  • Switchable Cas9 Nucleases And Uses Thereof
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Hbv And Viral Diseases And Disorders
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Delivery, Use And Therapeutic Applications Of The Crispr-Cas Systems And Compositions For Hbv And Viral Diseases And Disorders
  • Method Of Identifying And Treating A Person Having A Predisposition To Or Afflicted With A Cardiometabolic Disease
  • Comprehensive In Vitro Reporting Of Cleavage Events By Sequencing (Circle-Seq)
  • Methods And Systems For Processing Polynucleotides
  • Compositions For Transfecting Mrna Into A Cell And Their Applications
  • Homology Dependent Repair Genome Editing
  • Methods And Systems For Sample Processing Polynucleotides
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Nucleobase Editors Comprising Nucleic Acid Programmable Dna Binding Proteins
  • T Cell Balance Gene Expression, Compositions Of Matters And Methods Of Use Thereof
  • Bicyclic Urea Kinase Inhibitors And Uses Thereof
  • Methods Of Treating Cancer Harboring Hemizygous Loss Of Tp53
  • Methods For Identifying And Modulating Immune Phenotypes
  • Methods For Identifying New Therapeutic Agents
  • Engineered Nucleases Useful For Treatment Of Hemophilia A
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Targeting Bcl11a Enhancer Functional Regions For Fetal Hemoglobin Reinduction
  • Novel Methods For The Generation And Use Of Human Induced Neural Border Stem Cells
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Methods Of Treating Cancer Harboring Hemizygous Loss Of Tp53
  • T Cell Balance Gene Expression, Compositions Of Matters And Methods Of Use Thereof
  • Bicyclic Urea Kinase Inhibitors And Uses Thereof
  • Combination Therapies Using Cdk2 And Cdc25a Inhibitors
  • Capture Of Nucleic Acids Using A Nucleic Acid-Guided Nuclease-Based System
  • Escorted And Functionalized Guides For Crispr-Cas Systems
  • Method And System For Reducing The Likelihood Of A Spirochetes Infection In A Human Being
  • Random Crispr-Cas Deletion Mutant
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Engineered Crispr-Cas9 Nucleases With Altered Pam Specificity
  • Compositions And Methods For The Treatment Of Nucleotide Repeat Expansion Disorders
  • Methods And Compositions For Targeted Genetic Modifications And Methods Of Use
  • Single Cell Analysis Of Transposase Accessible Chromatin
  • Methods And Systems For Processing Polynucleotides
  • Method Of Treating Cancer With A Cancer Therapy In Combination With Another Therapeutic Agent
  • Novel Type Vi Crispr Enzymes And Systems
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Synthetic Rnas And Methods Of Use
  • Cancer Therapy
  • Methods And Systems For Processing Polynucleotides
  • Methods Of Diagnosing And Treating Cd55 Deficiency, Hyperactivation Of Complement, Angiopathic Thrombosis And Protein Losing Enteropathy (Chaple), A Newly Identified Orphan Disease
  • Tumor Infiltrating Lymphocytes And Methods Of Therapy
  • Switchable Cas9 Nucleases And Uses Thereof
  • Multiplex Drop-Off Digital Polymerase Chain Reaction Methods
  • Methods And Compositions Comprising Reduced Level Of Host Cell Proteins
  • B Cell Receptor Modification In B Cells
  • Delivery, Engineering And Optimization Of Tandem Guide Systems, Methods And Compositions For Sequence Manipulation
  • Comprehensive In Vitro Reporting Of Cleavage Events By Sequencing (Circle-Seq)
  • Methods And Compositions For Targeted Genetic Modifications And Methods Of Use
  • Novel Crispr Dna Targeting Enzymes And Systems
  • Genetic Construct Pmitoascpf1, Coding Nuclease Ascpf1 With Determinant Of Implantation In The Mitochondria Of Human Cells
  • Fusions Of Cas9 Domains And Nucleic Acid-Editing Domains
  • Crispr/Cas9 Correction Of Mutations In Dystrophin Exons 43, 45 And 52
  • Methods And Systems For Processing Polynucleotides
  • Delivery Of Negatively Charged Proteins Using Cationic Lipids
  • Methods And Compositions For Modifying A Single Stranded Target Nucleic Acid
  • Methods And Systems For Processing Polynucleotides
  • Increasing Specificity For Rna-Guided Genome Editing
  • Modified Cells And Methods Of Therapy
  • Novel Crispr Enzymes And Systems
  • Use Of The Emm Antigen As A Biomarker Of Inherited Gpi Deficiencies
  • Shmt Inhibitors
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Methods And Compositions For Enhancing Gene Editing
  • Production Of Fertile Xy Female Mice From Xy Mouse Es Cells
  • Lentiviral Nanoparticles
  • Methods And Systems For Processing Polynucleotides
  • Engineered Meganucleases With Recognition Sequences Found In The Human T Cell Receptor Alpha Constant Region Gene
  • Haploid Induction Enhancer
  • Nucleobase Editors And Uses Thereof
  • Methods And Systems For Processing Polynucleotides
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Methods For Genomic Integration
  • Production Of Viruses In Avian Eggs
  • Degradation Domain Modifications For Spatio-Temporal Control Of Rna-Guided Nucleases
  • Pluripotent Stem Cell-Derived 3d Retinal Tissue And Uses Thereof
  • Methods And Systems For Processing Polynucleotides
  • Methods For Genomic Integration
  • Methods And Compositions For Targeted Genetic Modifications And Methods Of Use
  • Method For Detecting In A Cell Rna-Protein Interaction
  • Engineered Crispr-Cas9 Nucleases
  • Long Non-Coding Rna Letn Serving As Tumor Marker And Therapeutic Target Point
  • Protected Guide Rnas (Pgrnas)
  • Coexpression Of Cas9 And Trex2 For Targeted Mutagenesis
  • Swine Comprising Modified Cd163 And Associated Methods
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Nucleic Acids Encoding Engineered Meganucleases With Recognition Sequences Found In The Human T Cell Receptor Alpha Constant Region Gene
  • Shmt Inhibitors
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Method For Converting Monocot Plant Genome Sequence In Which Nucleic Acid Base In Targeted Dna Sequence Is Specifically Converted, And Molecular Complex Used Therein
  • Methods Of Controlling Cannabinoid Synthesis In Plants Or Cells And Plants And Cells Produced Thereby
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Cas Variants For Gene Editing
  • Compositions And Methods For The Treatment Of Nucleotide Repeat Expansion Disorders
  • Small Tissue Ccr5−Mscs For Treatment Of Hiv
  • Evaluation And Improvement Of Nuclease Cleavage Specificity
  • Methods And Systems For Associating Physical And Genetic Properties Of Biological Particles
  • Methods And Systems For Processing Polynucleotides
  • Method For Generating Higher Order Genome Editing Libraries
  • Type Vi Crispr Orthologs And Systems
  • Methods And Systems For Processing Polynucleotides
  • Increasing Specificity For Rna-Guided Genome Editing
  • Method For Increasing Lycopene Content In Tomato Fruit
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Methods For Identifying And Treating Hemoglobinopathies
  • Engineered Crispr-Cas9 Nucleases
  • Anellovirus Compositions And Methods Of Use
  • Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System Proteins
  • Methods And Systems For Processing Polynucleotides
  • Compositions And Methods For Treatment Of Gcase Related Disease States
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Methods And Compositions For The Targeted Modification Of A Mouse Es Cell Genome
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Compositions For Detecting Secretion And Methods Of Use
  • Compositions For Use In Treating Autosomal Dominant Best1-Related Retinopathies
  • Inhibitors Of Mmej Pathway For Prevention And Treatment Of Pre-Myeloid And Myeloid Malignancies
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Homologous Recombination Factors
  • Genomewide Unbiased Identification Of Dsbs Evaluated By Sequencing (Guide-Seq)
  • Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
  • Methods And Systems For Processing Polynucleotides
  • Methods Of Treating Cancer Harboring Hemizygous Loss Of Tp53
  • Methods For Preparing Nucleic Acid Molecules For Sequencing
  • Novel Methods For The Generation And Use Of Human Induced Neural Border Stem Cells
  • Compositions For Transfecting Mrna Into A Cell And Their Applications
  • Delivery System For Functional Nucleases
  • Shmt Inhibitors
  • Compositions For Use In Treating Autosomal Dominant Best1-Related Retinopathies
  • Functional Genomics Using Crispr-Cas Systems, Compositions Methods, Screens And Applications Thereof
  • Compositions And Methods For Treatment Of Gcase Related Disease States
  • Methods And Systems For Processing Polynucleotides
  • Compositions And Methods Of Use Of Crispr-Cas Systems In Nucleotide Repeat Disorders
  • Adeno-Associated Viral Vectors For Gene Therapy
  • Delivery Systems And Kits For Gene Editing
  • Novel Type Vi Crispr Orthologs And Systems
  • Methods And Compositions For Generating Stable Transfected Cells
  • Inhibitors Of Mmej Pathway For Prevention And Treatment Of Pre-Myeloid And Myeloid Malignancies
  • Homologous Recombination Factors
  • Genetically Modified Cells, Tissues, And Organs For Treating Disease
  • Crispr Enzyme Mutations Reducing Off-Target Effects
  • Novel Family Of Rna-Programmable Endonucleases And Their Uses In Genome Editing And Other Applications
  • Nucleobase Editors And Uses Thereof
  • Cancer Therapy By Modifying Neoantigen Expression
  • Genomic Sequence Modification Method For Specifically Converting Nucleic Acid Bases Of Targeted Dna Sequence, And Molecular Complex For Use In Same
  • Targeted Modification Of Rat Genome
  • Selective Treatment Of Prmt5 Dependent Cancer
  • Extensible Recombinase Cascades
  • Crispr-Associated Transposase Systems And Methods Of Use Thereof
  • Methods For Genomic Integration
  • Gene Editing Of Deep Intronic Mutations
  • Using Truncated Guide Rnas (Tru-Grnas) To Increase Specificity For Rna-Guided Genome Editing
  • Instrument Systems For Integrated Sample Processing
  • Methods For Identifying Neoantigens
  • Functionalized Gel Beads
  • Methods And Compositions For Modifying Genomic Dna
  • Using Rna-Guided Foki Nucleases (Rfns) To Increase Specificity For Rna-Guided Genome Editing
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Novel Cas13b Orthologues Crispr Enzymes And Systems
  • Gene Editing Of Deep Intron Mutations
  • Genetically-Modified Cells Comprising A Modified Human T Cell Receptor Alpha Constant Region Gene
  • Production Of Fertile Xy Female Animals From Xy Es Cells
  • Compositions Comprising Circular Polyribonucleotides And Uses Thereof
  • Method To Bioengineer Designer Platelets Using Gene Editing And Stem Cell Methodologies
  • Compositions And Methods For Targeted Depletion, Enrichment, And Partitioning Of Nucleic Acids Using Crispr/Cas System Proteins
  • Processes And Systems For Preparation Of Nucleic Acid Sequencing Libraries And Libraries Prepared Using Same
  • Methods Of Treating Cancer Harboring Hemizygous Loss Of Tp53
  • Somatic Haploid Human Cell Line
  • Rna-Guided Targeting Of Genetic And Epigenomic Regulatory Proteins To Specific Genomic Loci
  • Cas9 Variants And Uses Thereof
  • Modulation Of Novel Immune Checkpoint Targets
  • Methods And Systems For Droplet-Based Single Cell Barcoding
  • Delivery And Use Of The Crispr-Cas Systems, Vectors And Compositions For Hepatic Targeting And Therapy
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nprot.2013.143

    DOI

    http://dx.doi.org/10.1038/nprot.2013.143

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1016534425

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24157548


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Biological Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0604", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Genetics", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Base Sequence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Culture Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cell Line", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Clustered Regularly Interspaced Short Palindromic Repeats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA End-Joining Repair", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Mutational Analysis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "DNA Repair", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Deoxyribonucleases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genetic Engineering", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genome", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Genotyping Techniques", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "HEK293 Cells", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Molecular Sequence Data", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mutagenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Transfection", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
                "McGovern Institute for Brain Research, Cambridge, Massachusetts, USA", 
                "Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.", 
                "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA", 
                "Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ran", 
            "givenName": "F Ann", 
            "id": "sg:person.01252441335.68", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252441335.68"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.38142.3c", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
                "McGovern Institute for Brain Research, Cambridge, Massachusetts, USA", 
                "Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.", 
                "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA", 
                "Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hsu", 
            "givenName": "Patrick D", 
            "id": "sg:person.01070077535.05", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070077535.05"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.66859.34", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Wright", 
            "givenName": "Jason", 
            "id": "sg:person.0645005643.46", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645005643.46"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.116068.8", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
                "Program in Biophysics, Harvard University, MIT, Cambridge, Massachusetts, USA", 
                "Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Agarwala", 
            "givenName": "Vineeta", 
            "id": "sg:person.01367725731.09", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367725731.09"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.116068.8", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
                "McGovern Institute for Brain Research, Cambridge, Massachusetts, USA", 
                "Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.", 
                "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Scott", 
            "givenName": "David A", 
            "id": "sg:person.01202227662.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202227662.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA", 
              "id": "http://www.grid.ac/institutes/grid.116068.8", 
              "name": [
                "Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA", 
                "McGovern Institute for Brain Research, Cambridge, Massachusetts, USA", 
                "Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.", 
                "Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Zhang", 
            "givenName": "Feng", 
            "id": "sg:person.0703626237.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703626237.20"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nbt1410", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1048577624", 
              "https://doi.org/10.1038/nbt1410"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.1542", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028726583", 
              "https://doi.org/10.1038/nmeth.1542"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrg2842", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1018939216", 
              "https://doi.org/10.1038/nrg2842"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.2532", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1023792803", 
              "https://doi.org/10.1038/nmeth.2532"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nprot.2011.431", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020679703", 
              "https://doi.org/10.1038/nprot.2011.431"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2508", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019888616", 
              "https://doi.org/10.1038/nbt.2508"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2507", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041881936", 
              "https://doi.org/10.1038/nbt.2507"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2170", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040026920", 
              "https://doi.org/10.1038/nbt.2170"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1775", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031104364", 
              "https://doi.org/10.1038/nbt.1775"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2460", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033598461", 
              "https://doi.org/10.1038/nbt.2460"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cr.2013.46", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038811201", 
              "https://doi.org/10.1038/cr.2013.46"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/ncomms2020", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020552108", 
              "https://doi.org/10.1038/ncomms2020"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2198", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043867750", 
              "https://doi.org/10.1038/nbt.2198"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrmicro2577", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1020345829", 
              "https://doi.org/10.1038/nrmicro2577"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-60761-753-2_15", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1045832829", 
              "https://doi.org/10.1007/978-1-60761-753-2_15"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/cr.2013.45", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006654084", 
              "https://doi.org/10.1038/cr.2013.45"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2501", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1024988605", 
              "https://doi.org/10.1038/nbt.2501"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt0502-446", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036940895", 
              "https://doi.org/10.1038/nbt0502-446"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nature09523", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009515358", 
              "https://doi.org/10.1038/nature09523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1927", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047844983", 
              "https://doi.org/10.1038/nbt.1927"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/317230a0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005647127", 
              "https://doi.org/10.1038/317230a0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt1319", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002154526", 
              "https://doi.org/10.1038/nbt1319"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nmeth.1653", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046255083", 
              "https://doi.org/10.1038/nmeth.1653"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.1755", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016004947", 
              "https://doi.org/10.1038/nbt.1755"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2647", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012543463", 
              "https://doi.org/10.1038/nbt.2647"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nprot.2008.70", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021659054", 
              "https://doi.org/10.1038/nprot.2008.70"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nbt.2623", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009511624", 
              "https://doi.org/10.1038/nbt.2623"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2013-10-24", 
        "datePublishedReg": "2013-10-24", 
        "description": "Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1\u20132 weeks, and modified clonal cell lines can be derived within 2\u20133 weeks.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nprot.2013.143", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.2376688", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2355012", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2683815", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2683902", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2500810", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1037502", 
            "issn": [
              "1754-2189", 
              "1750-2799"
            ], 
            "name": "Nature Protocols", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "11", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "8"
          }
        ], 
        "keywords": [
          "homology-directed repair", 
          "genome engineering", 
          "short palindromic repeats (CRISPR) adaptive immune system", 
          "guide RNA", 
          "double-nicking strategy", 
          "downstream functional studies", 
          "efficient genome engineering", 
          "cell lines", 
          "clonal cell lines", 
          "eukaryotic cells", 
          "off-target activity", 
          "mammalian cells", 
          "genome editing", 
          "genome alterations", 
          "nonhomologous end", 
          "target cleavage", 
          "targeted nucleases", 
          "gene modification", 
          "functional studies", 
          "adaptive immune system", 
          "RNA", 
          "target site", 
          "cleavage efficiency", 
          "nuclease", 
          "immune system", 
          "cells", 
          "mutants", 
          "CRISPR", 
          "powerful tool", 
          "editing", 
          "sequence", 
          "lines", 
          "cleavage", 
          "alterations", 
          "sites", 
          "repair", 
          "selection", 
          "activity", 
          "modification", 
          "engineering", 
          "tool", 
          "set of tools", 
          "generation", 
          "analysis", 
          "strategies", 
          "system", 
          "study", 
          "end", 
          "set", 
          "protocol", 
          "efficiency", 
          "weeks", 
          "high precision", 
          "target design", 
          "design", 
          "evaluation", 
          "precision", 
          "guidelines"
        ], 
        "name": "Genome engineering using the CRISPR-Cas9 system", 
        "pagination": "2281-2308", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1016534425"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nprot.2013.143"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24157548"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nprot.2013.143", 
          "https://app.dimensions.ai/details/publication/pub.1016534425"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:38", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_594.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nprot.2013.143"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nprot.2013.143'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nprot.2013.143'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nprot.2013.143'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nprot.2013.143'


     

    This table displays all metadata directly associated to this object as RDF triples.

    352 TRIPLES      21 PREDICATES      126 URIs      91 LITERALS      23 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nprot.2013.143 schema:about N05b1b4f04ead4e3ea619cd7f302023f3
    2 N25a401d655ce48409880e5acff225c30
    3 N3b74443deca44b65aad0bd2fc5735abf
    4 N3c6069308eb143aa827a96a03b83580c
    5 N493ddd6c4cd54a959e73edf1e176e6e5
    6 N5d2e940ec79d435ab2192fa25bb83c2c
    7 N606f7225d57d41579e4d57775ffc8271
    8 N699efeca5690477b8278d40f8a6b39bf
    9 N715380b620064a39b0c65461be1b7ff7
    10 N79f1a224640b4918a0921dcc5b2baef8
    11 N9ca291281db74f5d8fa4e1940d6ad204
    12 Na85701ebc6e34a11bcaeaba7708cde35
    13 Nb74e66c1401f48bfaa8854f68baf252a
    14 Ncb74efb594454f42b9530f28c79bb1e0
    15 Ndd28ff24dd174efebad41826f81645d0
    16 Ne72f01f937f54392bafcd828d7ff0ff9
    17 anzsrc-for:06
    18 anzsrc-for:0604
    19 schema:author N9e61ef5704dd42468d63d9219175106c
    20 schema:citation sg:pub.10.1007/978-1-60761-753-2_15
    21 sg:pub.10.1038/317230a0
    22 sg:pub.10.1038/cr.2013.45
    23 sg:pub.10.1038/cr.2013.46
    24 sg:pub.10.1038/nature09523
    25 sg:pub.10.1038/nbt.1755
    26 sg:pub.10.1038/nbt.1775
    27 sg:pub.10.1038/nbt.1927
    28 sg:pub.10.1038/nbt.2170
    29 sg:pub.10.1038/nbt.2198
    30 sg:pub.10.1038/nbt.2460
    31 sg:pub.10.1038/nbt.2501
    32 sg:pub.10.1038/nbt.2507
    33 sg:pub.10.1038/nbt.2508
    34 sg:pub.10.1038/nbt.2623
    35 sg:pub.10.1038/nbt.2647
    36 sg:pub.10.1038/nbt0502-446
    37 sg:pub.10.1038/nbt1319
    38 sg:pub.10.1038/nbt1410
    39 sg:pub.10.1038/ncomms2020
    40 sg:pub.10.1038/nmeth.1542
    41 sg:pub.10.1038/nmeth.1653
    42 sg:pub.10.1038/nmeth.2532
    43 sg:pub.10.1038/nprot.2008.70
    44 sg:pub.10.1038/nprot.2011.431
    45 sg:pub.10.1038/nrg2842
    46 sg:pub.10.1038/nrmicro2577
    47 schema:datePublished 2013-10-24
    48 schema:datePublishedReg 2013-10-24
    49 schema:description Targeted nucleases are powerful tools for mediating genome alteration with high precision. The RNA-guided Cas9 nuclease from the microbial clustered regularly interspaced short palindromic repeats (CRISPR) adaptive immune system can be used to facilitate efficient genome engineering in eukaryotic cells by simply specifying a 20-nt targeting sequence within its guide RNA. Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells, as well as generation of modified cell lines for downstream functional studies. To minimize off-target cleavage, we further describe a double-nicking strategy using the Cas9 nickase mutant with paired guide RNAs. This protocol provides experimentally derived guidelines for the selection of target sites, evaluation of cleavage efficiency and analysis of off-target activity. Beginning with target design, gene modifications can be achieved within as little as 1–2 weeks, and modified clonal cell lines can be derived within 2–3 weeks.
    50 schema:genre article
    51 schema:isAccessibleForFree true
    52 schema:isPartOf N7d4914a2effc4e559a0faffaa2823227
    53 Nc2709b35885440a8843f7a3cefa3cae0
    54 sg:journal.1037502
    55 schema:keywords CRISPR
    56 RNA
    57 activity
    58 adaptive immune system
    59 alterations
    60 analysis
    61 cell lines
    62 cells
    63 cleavage
    64 cleavage efficiency
    65 clonal cell lines
    66 design
    67 double-nicking strategy
    68 downstream functional studies
    69 editing
    70 efficiency
    71 efficient genome engineering
    72 end
    73 engineering
    74 eukaryotic cells
    75 evaluation
    76 functional studies
    77 gene modification
    78 generation
    79 genome alterations
    80 genome editing
    81 genome engineering
    82 guide RNA
    83 guidelines
    84 high precision
    85 homology-directed repair
    86 immune system
    87 lines
    88 mammalian cells
    89 modification
    90 mutants
    91 nonhomologous end
    92 nuclease
    93 off-target activity
    94 powerful tool
    95 precision
    96 protocol
    97 repair
    98 selection
    99 sequence
    100 set
    101 set of tools
    102 short palindromic repeats (CRISPR) adaptive immune system
    103 sites
    104 strategies
    105 study
    106 system
    107 target cleavage
    108 target design
    109 target site
    110 targeted nucleases
    111 tool
    112 weeks
    113 schema:name Genome engineering using the CRISPR-Cas9 system
    114 schema:pagination 2281-2308
    115 schema:productId N0e8a4264d1314815965cc27244f88164
    116 Nc4e9df9eb0234538949987b99c6b8ac4
    117 Nf760c8d7c3cd468991a463ea3b4cba05
    118 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016534425
    119 https://doi.org/10.1038/nprot.2013.143
    120 schema:sdDatePublished 2022-10-01T06:38
    121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    122 schema:sdPublisher N808b64bd73424682aaefa59c569dbb2b
    123 schema:url https://doi.org/10.1038/nprot.2013.143
    124 sgo:license sg:explorer/license/
    125 sgo:sdDataset articles
    126 rdf:type schema:ScholarlyArticle
    127 N05b1b4f04ead4e3ea619cd7f302023f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    128 schema:name Humans
    129 rdf:type schema:DefinedTerm
    130 N0e8a4264d1314815965cc27244f88164 schema:name dimensions_id
    131 schema:value pub.1016534425
    132 rdf:type schema:PropertyValue
    133 N25a401d655ce48409880e5acff225c30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Mutagenesis
    135 rdf:type schema:DefinedTerm
    136 N2be3d66064ed4dc592680685b4e8d088 rdf:first sg:person.01070077535.05
    137 rdf:rest Na83a49ae47dd4668a65e8f34a3034edd
    138 N3b74443deca44b65aad0bd2fc5735abf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    139 schema:name DNA Mutational Analysis
    140 rdf:type schema:DefinedTerm
    141 N3c6069308eb143aa827a96a03b83580c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Genotyping Techniques
    143 rdf:type schema:DefinedTerm
    144 N48ec7592209d40f2826d4384152bc69e rdf:first sg:person.01202227662.25
    145 rdf:rest N8af12cac0c3e4a12a86dc523ece11ed4
    146 N493ddd6c4cd54a959e73edf1e176e6e5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Genetic Engineering
    148 rdf:type schema:DefinedTerm
    149 N5d2e940ec79d435ab2192fa25bb83c2c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name HEK293 Cells
    151 rdf:type schema:DefinedTerm
    152 N606f7225d57d41579e4d57775ffc8271 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name DNA End-Joining Repair
    154 rdf:type schema:DefinedTerm
    155 N67c08185cedb4dc2bc0d8c920d8032e7 rdf:first sg:person.01367725731.09
    156 rdf:rest N48ec7592209d40f2826d4384152bc69e
    157 N699efeca5690477b8278d40f8a6b39bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Transfection
    159 rdf:type schema:DefinedTerm
    160 N715380b620064a39b0c65461be1b7ff7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name DNA Repair
    162 rdf:type schema:DefinedTerm
    163 N79f1a224640b4918a0921dcc5b2baef8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Cell Culture Techniques
    165 rdf:type schema:DefinedTerm
    166 N7d4914a2effc4e559a0faffaa2823227 schema:volumeNumber 8
    167 rdf:type schema:PublicationVolume
    168 N808b64bd73424682aaefa59c569dbb2b schema:name Springer Nature - SN SciGraph project
    169 rdf:type schema:Organization
    170 N8af12cac0c3e4a12a86dc523ece11ed4 rdf:first sg:person.0703626237.20
    171 rdf:rest rdf:nil
    172 N9ca291281db74f5d8fa4e1940d6ad204 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    173 schema:name Molecular Sequence Data
    174 rdf:type schema:DefinedTerm
    175 N9e61ef5704dd42468d63d9219175106c rdf:first sg:person.01252441335.68
    176 rdf:rest N2be3d66064ed4dc592680685b4e8d088
    177 Na83a49ae47dd4668a65e8f34a3034edd rdf:first sg:person.0645005643.46
    178 rdf:rest N67c08185cedb4dc2bc0d8c920d8032e7
    179 Na85701ebc6e34a11bcaeaba7708cde35 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Deoxyribonucleases
    181 rdf:type schema:DefinedTerm
    182 Nb74e66c1401f48bfaa8854f68baf252a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    183 schema:name Clustered Regularly Interspaced Short Palindromic Repeats
    184 rdf:type schema:DefinedTerm
    185 Nc2709b35885440a8843f7a3cefa3cae0 schema:issueNumber 11
    186 rdf:type schema:PublicationIssue
    187 Nc4e9df9eb0234538949987b99c6b8ac4 schema:name doi
    188 schema:value 10.1038/nprot.2013.143
    189 rdf:type schema:PropertyValue
    190 Ncb74efb594454f42b9530f28c79bb1e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    191 schema:name Genome
    192 rdf:type schema:DefinedTerm
    193 Ndd28ff24dd174efebad41826f81645d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    194 schema:name Base Sequence
    195 rdf:type schema:DefinedTerm
    196 Ne72f01f937f54392bafcd828d7ff0ff9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    197 schema:name Cell Line
    198 rdf:type schema:DefinedTerm
    199 Nf760c8d7c3cd468991a463ea3b4cba05 schema:name pubmed_id
    200 schema:value 24157548
    201 rdf:type schema:PropertyValue
    202 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
    203 schema:name Biological Sciences
    204 rdf:type schema:DefinedTerm
    205 anzsrc-for:0604 schema:inDefinedTermSet anzsrc-for:
    206 schema:name Genetics
    207 rdf:type schema:DefinedTerm
    208 sg:grant.2355012 http://pending.schema.org/fundedItem sg:pub.10.1038/nprot.2013.143
    209 rdf:type schema:MonetaryGrant
    210 sg:grant.2376688 http://pending.schema.org/fundedItem sg:pub.10.1038/nprot.2013.143
    211 rdf:type schema:MonetaryGrant
    212 sg:grant.2500810 http://pending.schema.org/fundedItem sg:pub.10.1038/nprot.2013.143
    213 rdf:type schema:MonetaryGrant
    214 sg:grant.2683815 http://pending.schema.org/fundedItem sg:pub.10.1038/nprot.2013.143
    215 rdf:type schema:MonetaryGrant
    216 sg:grant.2683902 http://pending.schema.org/fundedItem sg:pub.10.1038/nprot.2013.143
    217 rdf:type schema:MonetaryGrant
    218 sg:journal.1037502 schema:issn 1750-2799
    219 1754-2189
    220 schema:name Nature Protocols
    221 schema:publisher Springer Nature
    222 rdf:type schema:Periodical
    223 sg:person.01070077535.05 schema:affiliation grid-institutes:grid.38142.3c
    224 schema:familyName Hsu
    225 schema:givenName Patrick D
    226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070077535.05
    227 rdf:type schema:Person
    228 sg:person.01202227662.25 schema:affiliation grid-institutes:grid.116068.8
    229 schema:familyName Scott
    230 schema:givenName David A
    231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202227662.25
    232 rdf:type schema:Person
    233 sg:person.01252441335.68 schema:affiliation grid-institutes:grid.38142.3c
    234 schema:familyName Ran
    235 schema:givenName F Ann
    236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01252441335.68
    237 rdf:type schema:Person
    238 sg:person.01367725731.09 schema:affiliation grid-institutes:grid.116068.8
    239 schema:familyName Agarwala
    240 schema:givenName Vineeta
    241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367725731.09
    242 rdf:type schema:Person
    243 sg:person.0645005643.46 schema:affiliation grid-institutes:grid.66859.34
    244 schema:familyName Wright
    245 schema:givenName Jason
    246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645005643.46
    247 rdf:type schema:Person
    248 sg:person.0703626237.20 schema:affiliation grid-institutes:grid.116068.8
    249 schema:familyName Zhang
    250 schema:givenName Feng
    251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703626237.20
    252 rdf:type schema:Person
    253 sg:pub.10.1007/978-1-60761-753-2_15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045832829
    254 https://doi.org/10.1007/978-1-60761-753-2_15
    255 rdf:type schema:CreativeWork
    256 sg:pub.10.1038/317230a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005647127
    257 https://doi.org/10.1038/317230a0
    258 rdf:type schema:CreativeWork
    259 sg:pub.10.1038/cr.2013.45 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006654084
    260 https://doi.org/10.1038/cr.2013.45
    261 rdf:type schema:CreativeWork
    262 sg:pub.10.1038/cr.2013.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038811201
    263 https://doi.org/10.1038/cr.2013.46
    264 rdf:type schema:CreativeWork
    265 sg:pub.10.1038/nature09523 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009515358
    266 https://doi.org/10.1038/nature09523
    267 rdf:type schema:CreativeWork
    268 sg:pub.10.1038/nbt.1755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016004947
    269 https://doi.org/10.1038/nbt.1755
    270 rdf:type schema:CreativeWork
    271 sg:pub.10.1038/nbt.1775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031104364
    272 https://doi.org/10.1038/nbt.1775
    273 rdf:type schema:CreativeWork
    274 sg:pub.10.1038/nbt.1927 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047844983
    275 https://doi.org/10.1038/nbt.1927
    276 rdf:type schema:CreativeWork
    277 sg:pub.10.1038/nbt.2170 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040026920
    278 https://doi.org/10.1038/nbt.2170
    279 rdf:type schema:CreativeWork
    280 sg:pub.10.1038/nbt.2198 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043867750
    281 https://doi.org/10.1038/nbt.2198
    282 rdf:type schema:CreativeWork
    283 sg:pub.10.1038/nbt.2460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033598461
    284 https://doi.org/10.1038/nbt.2460
    285 rdf:type schema:CreativeWork
    286 sg:pub.10.1038/nbt.2501 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024988605
    287 https://doi.org/10.1038/nbt.2501
    288 rdf:type schema:CreativeWork
    289 sg:pub.10.1038/nbt.2507 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041881936
    290 https://doi.org/10.1038/nbt.2507
    291 rdf:type schema:CreativeWork
    292 sg:pub.10.1038/nbt.2508 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019888616
    293 https://doi.org/10.1038/nbt.2508
    294 rdf:type schema:CreativeWork
    295 sg:pub.10.1038/nbt.2623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009511624
    296 https://doi.org/10.1038/nbt.2623
    297 rdf:type schema:CreativeWork
    298 sg:pub.10.1038/nbt.2647 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012543463
    299 https://doi.org/10.1038/nbt.2647
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1038/nbt0502-446 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036940895
    302 https://doi.org/10.1038/nbt0502-446
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1038/nbt1319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002154526
    305 https://doi.org/10.1038/nbt1319
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1038/nbt1410 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048577624
    308 https://doi.org/10.1038/nbt1410
    309 rdf:type schema:CreativeWork
    310 sg:pub.10.1038/ncomms2020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020552108
    311 https://doi.org/10.1038/ncomms2020
    312 rdf:type schema:CreativeWork
    313 sg:pub.10.1038/nmeth.1542 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028726583
    314 https://doi.org/10.1038/nmeth.1542
    315 rdf:type schema:CreativeWork
    316 sg:pub.10.1038/nmeth.1653 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046255083
    317 https://doi.org/10.1038/nmeth.1653
    318 rdf:type schema:CreativeWork
    319 sg:pub.10.1038/nmeth.2532 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023792803
    320 https://doi.org/10.1038/nmeth.2532
    321 rdf:type schema:CreativeWork
    322 sg:pub.10.1038/nprot.2008.70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021659054
    323 https://doi.org/10.1038/nprot.2008.70
    324 rdf:type schema:CreativeWork
    325 sg:pub.10.1038/nprot.2011.431 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020679703
    326 https://doi.org/10.1038/nprot.2011.431
    327 rdf:type schema:CreativeWork
    328 sg:pub.10.1038/nrg2842 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018939216
    329 https://doi.org/10.1038/nrg2842
    330 rdf:type schema:CreativeWork
    331 sg:pub.10.1038/nrmicro2577 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020345829
    332 https://doi.org/10.1038/nrmicro2577
    333 rdf:type schema:CreativeWork
    334 grid-institutes:grid.116068.8 schema:alternateName Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA
    335 Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts, USA
    336 schema:name Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
    337 Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA
    338 Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.
    339 Harvard-MIT Division of Health Sciences and Technology, MIT, Cambridge, Massachusetts, USA
    340 McGovern Institute for Brain Research, Cambridge, Massachusetts, USA
    341 Program in Biophysics, Harvard University, MIT, Cambridge, Massachusetts, USA
    342 rdf:type schema:Organization
    343 grid-institutes:grid.38142.3c schema:alternateName Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA
    344 schema:name Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
    345 Department of Biological Engineering, MIT, Cambridge, Massachusetts, USA
    346 Department of Brain and Cognitive Sciences, MIT, Cambridge, Massachusetts, USA.
    347 Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts, USA
    348 McGovern Institute for Brain Research, Cambridge, Massachusetts, USA
    349 rdf:type schema:Organization
    350 grid-institutes:grid.66859.34 schema:alternateName Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
    351 schema:name Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, Massachusetts, USA
    352 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...